MR编号 | NL/H/2968/001 |
---|
药品名称 | Vesomni |
---|
活性成分 | - Solifenacin succinate 6.0 mg
- Tamsulosin hydrochloride 400.0 µg
|
---|
剂型 | Modified-release tablet |
---|
上市许可持有人 | Astellas Pharma Europe BV
Sylviusweg 62
2333 BE Leiden
The Netherlands |
---|
参考成员国 - 产品名称 | Netherlands (NL) Vesomni |
---|
互认成员国 - 产品名称 | - Portugal (PT)
- Italy (IT)
- Hungary (HU)
VESOMNI 6 mg/0,4 mg módosított hatóanyag-leadású tabletta - Bulgaria (BG)
Vesomni - Romania (RO)
VESOMNI 6 mg/0,4 mg comprimate cu eliberare modificată - Slovenia (SI)
- Croatia (HR)
- Denmark (DK)
Vesomni - Belgium (BE)
Vesomni - Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Vesomni 6 mg/0,4 mg Tabletten mit veränderter Wirkstofffreisetzung - Spain (ES)
- Greece (GR)
VESOMNI - Sweden (SE)
- Norway (NO)
Urizia - Finland (FI)
- Czechia (CZ)
Vestona - Slovakia (SK)
Vesomni 6 mg/0,4 mg tablety s riadeným uvoľňovaním
|
---|
许可日期 | 2013/10/07 |
---|
最近更新日期 | 2025/02/03 |
---|
药物ATC编码 | - G04CA Alpha-adrenoreceptor antagonists
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|